Browse Category

NYSE:WST News 23 October 2025 - 12 January 2026

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 23.10.2025

West Pharmaceutical Services posted Q3 profit of $140 million, or $1.92 per share, beating estimates and raising FY25 guidance. Enphase Energy shares fell 11% in a month, with a 1-year total return of -54%, as valuation concerns persist. CBRE Group reported Q3 net income of $225 million and lifted full-year EPS guidance. Tractor Supply beat Q3 earnings estimates and raised its full-year EPS outlook to $2.06–$2.13.
Go toTop